These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29289594)

  • 1. CD4 + T cells promote renal cell carcinoma proliferation via modulating YBX1.
    Wang Y; Wang Y; Xu L; Lu X; Fu D; Su J; Geng H; Qin G; Chen R; Quan C; Niu Y; Yue D
    Exp Cell Res; 2018 Feb; 363(1):95-101. PubMed ID: 29289594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.
    Yue D; Wang Y; Sun Y; Niu Y; Chang C
    Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis.
    Wang Y; Yue D; Xiao M; Qi C; Chen Y; Sun D; Zhang N; Chen R
    J Proteome Res; 2015 Feb; 14(2):804-13. PubMed ID: 25497084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2.
    Cui Q; Wang C; Liu S; Du R; Tian S; Chen R; Geng H; Subramanian S; Niu Y; Wang Y; Yue D
    Cell Cycle; 2021 Nov; 20(22):2413-2427. PubMed ID: 34709966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2α and estrogen receptor β signals.
    Song W; Yeh CR; He D; Wang Y; Xie H; Pang ST; Chang LS; Li L; Yeh S
    Oncotarget; 2015 Aug; 6(22):19290-304. PubMed ID: 26079540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.
    Yeh CR; Ou ZY; Xiao GQ; Guancial E; Yeh S
    Oncotarget; 2015 Dec; 6(42):44346-59. PubMed ID: 26587829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting newly identified ERβ/TGF-β1/SMAD3 signals with the FDA-approved anti-estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma.
    Song W; He D; Chen Y; Yeh CR; Hsu I; Huang Q; Zhang X; Chang LS; Zuo L; Chen J; Doersch KM; Chang C; Li L; Yeh S
    Mol Oncol; 2018 Dec; 12(12):2055-2071. PubMed ID: 30171816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR) → c-Myc signals.
    Song W; Li L; He D; Xie H; Chen J; Yeh CR; Chang LS; Yeh S; Chang C
    Cancer Lett; 2015 Nov; 368(1):71-78. PubMed ID: 26231735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-β1 enhances proliferative and metastatic potential by up-regulating lymphoid enhancer-binding factor 1/integrin αMβ2 in human renal cell carcinoma.
    Liu Y; Shang D
    Mol Cell Biochem; 2020 Feb; 465(1-2):165-174. PubMed ID: 31848806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal regulation of hypoxia-inducible factor 2α and GLI1 expression associated with the radioresistance of renal cell carcinoma.
    Zhou J; Wu K; Gao D; Zhu G; Wu D; Wang X; Chen Y; Du Y; Song W; Ma Z; Authement C; Saha D; Hsieh JT; He D
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):942-51. PubMed ID: 25585786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXA2 activates HIF2α expression to promote tumor progression and is regulated by the E3 ubiquitin ligase VHL in renal cell carcinoma.
    Yang D; Li Q; Lu P; Wu D; Li W; Meng X; Xing M; Shangguan W; Chen B; Yang J; Zhang Z; Wang Z; Huang DCS; Zhao Q
    J Biol Chem; 2024 Jan; 300(1):105535. PubMed ID: 38072043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIGH3 is overexpressed in clear cell renal cell carcinoma.
    Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
    Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
    Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
    Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY; Poellinger L; Walker CL
    Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression - Important implications for epithelial to mesenchymal transition (EMT) in renal cell carcinoma.
    Feldkoren B; Hutchinson R; Rapoport Y; Mahajan A; Margulis V
    Exp Cell Res; 2017 Jun; 355(2):57-66. PubMed ID: 28363829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA BX357664 regulates cell proliferation and epithelial-to-mesenchymal transition via inhibition of TGF-β1/p38/HSP27 signaling in renal cell carcinoma.
    Liu Y; Qian J; Li X; Chen W; Xu A; Zhao K; Hua Y; Huang Z; Zhang J; Liang C; Su S; Li P; Shao P; Li J; Qin C; Wang Z
    Oncotarget; 2016 Dec; 7(49):81410-81422. PubMed ID: 27806310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
    Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
    Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA RP11-567G11.1 accelerates the proliferation and invasion of renal cell carcinoma through activating the Notch pathway.
    Liu S; Liu WH; Diao ZL; Zhang AH; Guo W; Han X; Huang HD
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4738-4744. PubMed ID: 32432737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASC-J9 suppresses renal cell carcinoma progression by targeting an androgen receptor-dependent HIF2α/VEGF signaling pathway.
    He D; Li L; Zhu G; Liang L; Guan Z; Chang L; Chen Y; Yeh S; Chang C
    Cancer Res; 2014 Aug; 74(16):4420-30. PubMed ID: 24924778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.